These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11192825)

  • 1. Molecular detection of codon 12 K-RAS mutations in circulating DNA from serum of colorectal cancer patients.
    Salbe C; Trevisiol C; Ferruzzi E; Mancuso T; Nascimbeni R; Di Fabio F; Salerni B; Dittadi R
    Int J Biol Markers; 2000; 15(4):300-7. PubMed ID: 11192825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of isolated tumor cells by polymerase chain reaction-restriction fragment length polymorphism for K-ras mutations in tissue samples of 199 colorectal cancer patients.
    Dieterle CP; Conzelmann M; Linnemann U; Berger MR
    Clin Cancer Res; 2004 Jan; 10(2):641-50. PubMed ID: 14760087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.
    Conzelmann M; Linnemann U; Berger MR
    Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low correspondence between K-ras mutations in pancreatic cancer tissue and detection of K-ras mutations in circulating DNA.
    Marchese R; Muleti A; Pasqualetti P; Bucci B; Stigliano A; Brunetti E; De Angelis M; Mazzoni G; Tocchi A; Brozzetti S
    Pancreas; 2006 Mar; 32(2):171-7. PubMed ID: 16552337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic mutation screening: identification of individuals harboring K-ras mutations with the use of plasma DNA.
    Kopreski MS; Benko FA; Borys DJ; Khan A; McGarrity TJ; Gocke CD
    J Natl Cancer Inst; 2000 Jun; 92(11):918-23. PubMed ID: 10841827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are high initial CEA and CA 19-9 levels associated with the presence of K-ras mutation in patients with metastatic colorectal cancer?
    Selcukbiricik F; Bilici A; Tural D; Erdamar S; Soyluk O; Buyukunal E; Demirelli F; Serdengecti S
    Tumour Biol; 2013 Aug; 34(4):2233-9. PubMed ID: 23625655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of circulating KRAS2 gene mutations in colorectal cancer with distant metastases.
    Trevisiol C; Di Fabio F; Nascimbeni R; Peloso L; Salbe C; Ferruzzi E; Salerni B; Gion M
    Int J Biol Markers; 2006; 21(4):223-8. PubMed ID: 17177160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype.
    Bazan V; Migliavacca M; Zanna I; Tubiolo C; Grassi N; Latteri MA; La Farina M; Albanese I; Dardanoni G; Salerno S; Tomasino RM; Labianca R; Gebbia N; Russo A
    Ann Oncol; 2002 Sep; 13(9):1438-46. PubMed ID: 12196370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A two-step enriched-nested PCR technique enhances sensitivity for detection of codon 12 K-ras mutations in pancreatic adenocarcinoma.
    Banerjee SK; Makdisi WF; Weston AP; Campbell DR
    Pancreas; 1997 Jul; 15(1):16-24. PubMed ID: 9211488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of pancreatic carcinoma: diagnostic value of K-ras mutations in circulating DNA from serum.
    Theodor L; Melzer E; Sologov M; Idelman G; Friedman E; Bar-Meir S
    Dig Dis Sci; 1999 Oct; 44(10):2014-9. PubMed ID: 10548352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of K-ras mutations in stools of patients with colorectal cancer by mutant-enriched PCR.
    Nollau P; Moser C; Weinland G; Wagener C
    Int J Cancer; 1996 May; 66(3):332-6. PubMed ID: 8621253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Screening for K-ras mutations in colorectal and lung cancers by using a novel real-time PCR with ADx-K-ras kit and Sanger DNA sequencing].
    Zhang HP; Fu L; Chen PQ; Ye YB; Ji TH; Zheng LM
    Zhonghua Bing Li Xue Za Zhi; 2010 Nov; 39(11):757-61. PubMed ID: 21215167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disseminated colorectal tumor cells in organs prone to metastasis detected by new double enriched nested-PCR in comparison with recognized assays.
    Kraus MC; Linnemann U; Berger MR
    Oncol Rep; 2011 May; 25(5):1421-9. PubMed ID: 21369707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitive detection of K-ras mutations augments diagnosis of colorectal cancer metastases in the liver.
    Schimanski CC; Linnemann U; Berger MR
    Cancer Res; 1999 Oct; 59(20):5169-75. PubMed ID: 10537293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H-ras oncogene point mutations in arthritic synovium.
    Roivainen A; Jalava J; Pirilä L; Yli-Jama T; Tiusanen H; Toivanen P
    Arthritis Rheum; 1997 Sep; 40(9):1636-43. PubMed ID: 9324018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular detection of APC, K- ras, and p53 mutations in the serum of colorectal cancer patients as circulating biomarkers.
    Wang JY; Hsieh JS; Chang MY; Huang TJ; Chen FM; Cheng TL; Alexandersen K; Huang YS; Tzou WS; Lin SR
    World J Surg; 2004 Jul; 28(7):721-6. PubMed ID: 15185002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of mutated K-ras DNA in urine, plasma, and serum of patients with colorectal carcinoma or adenomatous polyps.
    Su YH; Wang M; Brenner DE; Norton PA; Block TM
    Ann N Y Acad Sci; 2008 Aug; 1137():197-206. PubMed ID: 18837947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discordance between K-ras mutations in bone marrow micrometastases and the primary tumor in colorectal cancer.
    Tórtola S; Steinert R; Hantschick M; Peinado MA; Gastinger I; Stosiek P; Lippert H; Schlegel W; Reymond MA
    J Clin Oncol; 2001 Jun; 19(11):2837-43. PubMed ID: 11387355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of codon 61 point mutations of the K-ras gene in lung and colorectal cancers by enriched PCR.
    Toyooka S; Tsukuda K; Ouchida M; Tanino M; Inaki Y; Kobayashi K; Yano M; Soh J; Kobatake T; Shimizu N; Shimizu K
    Oncol Rep; 2003; 10(5):1455-9. PubMed ID: 12883723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The balanced induction of K-ras codon 12 and 13 mutations in mucosa differs from their ratio in neoplastic tissues.
    Kraus MC; Seelig MH; Linnemann U; Berger MR
    Int J Oncol; 2006 Oct; 29(4):957-64. PubMed ID: 16964391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.